Illustration: Sarah Grillo/Axios

Due to the lack of new antibiotics in the pipeline, current drugs must be better monitored and prescribed before the problem of antimicrobial resistance (AMR) reaches a "Titanic" stage, World Health Organization scientists warned Tuesday as they launch a campaign to promote the use of a monitoring tool, AWaRe.

Why it matters: The growing level of superbugs is a potentially "catastrophic" global threat that could have a yearly death toll of 10 million people by 2050. WHO says using AWaRe would be one tool in promoting its goal that 60% of all antibiotics used come from the "access" category of antibiotics, or what's typically thought of as the first or second line of defense.

The backdrop: WHO's essential medicines list divides antibiotics into 3 categories: "access," "watch," and "reserve" with recommendations for when each category should be used.

But, WHO scientists say too many countries either don't have appropriate access to antibiotics or are using antibiotics incorrectly — including for wrong diagnoses, animal husbandry and even plants — causing an increase in AMR.

  • "We need to keep antibiotics working for everyone," which calls for proper monitoring and management of prescriptions, Mariângela Simão, WHO's assistant director general for access to medicines, said in a press briefing.
  • The scientists pointed to the concerning spread of resistant gram-negative bacteria, including Acinetobacter, E. coli and Klebsiella pneumoniae, which often strike hospital patients with problems like pneumonia, bloodstream infections, sepsis, wound or surgical site infections, and meningitis.
  • Another problem is the huge gap between low- and middle-income countries in access to effective and appropriate antibiotics. Simão says more than 1 million children die due to treatable pneumonia, likely from lack of access to appropriate antibiotics.

The bottom line: If AMR is not halted, "this will probably lead to a halt in modern medicine as we know it today," says Hanan Balkhy, WHO's assistant director general for antimicrobial resistance.

Go deeper:

Go deeper

Updated 52 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Global: Total confirmed cases as of 4:30 p.m. ET: 21,020,216 — Total deaths: 761,393— Total recoveries: 13,048,303Map.
  2. U.S.: Total confirmed cases as of 4:30 p.m. ET: 5,289,323 — Total deaths: 167,948 — Total recoveries: 1,774,648 — Total tests: 64,831,306Map.
  3. Health: CDC: Survivors of COVID-19 have up to three months of immunity Fauci believes normalcy will return by "the end of 2021" with vaccine — The pandemic's toll on mental health.
  4. Business: How small businesses got stiffed — Unemployment starts moving in the right direction.
  5. Cities: Coronavirus pandemic dims NYC's annual 9/11 Tribute in Light.
  6. Politics: Biden signals fall strategy with new ads.

Harris: "Women are going to be a priority" in Biden administration

Sen. Kamala Harris at an event in Wilmington, Del. Photo: Drew Angerer/Getty Images

In her first sit-down interview since being named Joe Biden's running mate, Sen. Kamala Harris talked about what she'll do to fight for women if elected VP, and how the Democrats are thinking about voter turnout strategies ahead of November.

What they're saying: "In a Biden-Harris administration women are going to be a priority, understanding that women have many priorities and all of them must be acknowledged," Harris told The 19th*'s Errin Haines-Whack.

Facebook goes after Apple

Illustration: Lazaro Gamio/Axios

Facebook is seeking to force a face-off with Apple over its 30% in-app purchase commission fee, which Facebook suggests hurts small businesses struggling to get by during the pandemic.

The big picture: Facebook has never publicly gone after Apple, a key strategic partner, this aggressively. Both companies face antitrust scrutiny, which in Apple's case has centered on the very fee structure Facebook is now attacking.